AI-Driven Target & Drug Discovery Platform

AI-Driven Target & Drug Discovery Platform Alt

Accelerate target identification, modality-specific design, and hit-to-lead optimization with agentic AI workflows built for biotech R&D teams.

Platform Overview

A unified ecosystem combining:

1 Target discovery engines

Multi-omics AI + embeddings + KGs for identifying disease-relevant targets.

2 Modality-specific design modules

Small molecules, peptides, proximity inducers.

3 Predictive & generative AI model stack

Structure, function, binding, docking, ADMET, PPI.

4 Dry + wet-lab integration

Active-learning cycles guiding experiments.

Multi-Omics Pipelines

5 AI-native R&D orchestration

Strategy → workflows → models → insights → iteration.

AI Healthcare Diagnostics
CORE MODULES

Small Molecules Platform

What it enables

  • Covalent & non-covalent inhibitors
  • GPCRs, kinases, ion channels
  • Enzymes & nuclear receptors
  • Allosteric & cryptic pocket targeting
  • SAR automation and prioritization
  • Full ADMET property optimization
  • Selectivity scoring vs isoforms/mutants

AI Capabilities

  • Docking
  • Binding site detection
  • Virtual screening
  • Selectivity + off-target prediction
  • Lead optimization scoring
Add Button
CORE MODULES

Peptide Platform

What it enables

  • Linear / cyclic / hybrid peptides
  • Non-natural amino acids
  • Phage/RNA display integration
  • Optimization for permeability & oral availability
  • Peptide → small-molecule conversion workflows

AI Capabilities

  • Sequence-to-structure prediction
  • Activity prediction
  • Stability modeling
  • Generative peptide design
Add Button
CORE MODULES

Proximity Inducers Platform (PROTACs, glues, disruptors)

What it enables

  • Ternary complex prediction
  • Molecular glues & degraders
  • PPI disruptors
  • Native + induced PPI targeting
  • Membrane supramolecular assemblies
  • Multi-modality workflows

AI Capabilities

  • PPI interface prediction
  • Ligand-induced complex assembly
  • Generative designs for degraders/disruptors
Add Button

Discover More Related Case Studies

Didn’t find exactly what you were looking for?

Tell us what you’re building – we’ll map out the options, evaluate feasibility, and recommend the optimal technical pathway.

Get a consultation

For Whom

For early-stage biotechs

  • No internal data science team

  • Need to show investors a clear AI-R&D plan

  • Lack of validated target discovery workflows

For growth-stage & platform biotechs

  • Scaling multiple therapeutic programs

  • Fragmented data across wet/dry labs

  • Need for unified internal AI platform

For pharma & CRO R&D

  • Throughput & cost pressure

  • Reproducibility & regulatory complexity

  • Slow cycle times between experiments

Get in touch with us.

We’re here to assist you.

Gary Martin

Head of Biotech AI Partnerships

Chat in WhatsApp


    Your AI Idea, Our Technical Precision


    From pilot concepts to full-stack pipelines — tell us where you are and where you need to go.




    Drop or upload a file with project requirements in zip, pdf, pptx, docx